Vaginal Estrogen for Asymptomatic Microscopic Hematuria

Status unconfirmed · Phase 4

Conditions studied: Asymptomatic Microscopic Hematuria

In brief

The specific aim of this protocol is to determine whether vaginal estrogen is an effective treatment for asymptomatic microscopic hematuria in postmenopausal women. The investigators hypothesize that women who use vaginal estrogen for three months will be more likely to have resolution of their asymptomatic microscopic hematuria compared with women who do not use vaginal estrogen.

Key facts

Study ID
NCT03033160
Run by
Boston Urogynecology Associates
People needed
68
Starts
2016-12-01
Expected to finish
2020-12-30
Last updated by the study team
2017-10-12

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.